Bain Capital Life Sciences Investors, LLC Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$799.3B
Holdings
23
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (23 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NAMSNEWAMSTERDAM PHARMA COMPANY | 10,719,110 | $194.1B | 24.29% | |
| 2 | CDTXCIDARA THERAPEUTICS INC | 2,500,680 | $121.8B | 15.24% | |
| 3 | NUVLNUVALENT INC | 1,447,267 | $110.4B | 13.82% | |
| 4 | PHVSPHARVARIS N V | 3,303,381 | $58.1B | 7.27% | |
| 5 | DNTHDIANTHUS THERAPEUTICS INC | 2,482,250 | $46.2B | 5.79% | |
| 6 | YB4PSAVARA INC | 17,600,621 | $40.1B | 5.02% | |
| 7 | SLDBSOLID BIOSCIENCES INC | 7,911,669 | $38.5B | 4.82% | |
| 8 | IRONDISC MEDICINE INC | 583,500 | $30.9B | 3.87% | |
| 9 | OLMAOLEMA PHARMACEUTICALS INC | 6,843,954 | $29.2B | 3.65% | |
| 10 | RPIDRAPID MICRO BIOSYSTEMS INC | 8,434,560 | $29.1B | 3.64% | |
| 11 | UPBUPSTREAM BIO INC | 2,439,538 | $26.8B | 3.35% | |
| 12 | CABACABALETTA BIO INC | 9,677,125 | $14.7B | 1.84% | |
| 13 | TNGXTANGO THERAPEUTICS INC | 2,712,008 | $13.9B | 1.74% | |
| 14 | ANNXANNEXON INC | 5,249,069 | $12.6B | 1.58% | |
| 15 | KYTXKYVERNA THERAPEUTICS INC | 3,368,370 | $10.3B | 1.29% | |
| 16 | AVIRATEA PHARMACEUTICALS INC | 2,485,638 | $8.9B | 1.12% | |
| 17 | XLOXILIO THERAPEUTICS INC | 4,566,817 | $3.1B | 0.39% | |
| 18 | IPSCCENTURY THERAPEUTICS INC | 5,410,361 | $3.0B | 0.38% | |
| 19 | —MERSANA THERAPEUTICS INC | 8,663,673 | $2.6B | 0.32% | |
| 20 | CCCCC4 THERAPEUTICS INC | 1,111,910 | $1.6B | 0.20% | |
| 21 | IVVDINVIVYD INC | 1,799,595 | $1.3B | 0.16% | |
| 22 | XFORX4 PHARMACEUTICALS INC | 563,859 | $1.1B | 0.13% | |
| 23 | NAMSNEWAMSTERDAM PHARMA COMPANY | 100,000 | $800.0M | 0.10% |